Key result
Diabetic cardiomyopathy is driven by altered mitochondrial function and metabolism, and alternative treatments like resveratrol may represent a promising supplement to current clinical therapy.
This review emphasizes the role of mitochondrial dysfunction in diabetic cardiomyopathy and suggests resveratrol as a promising therapeutic supplement.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for redox alterations in diabetic cardiomyopathy; prospective trials needed before clinical translation.
Sung et al. (2015) conducted a review in Diabetic Cardiomyopathy. Resveratrol was evaluated. Diabetic cardiomyopathy is driven by altered mitochondrial function and metabolism, and alternative treatments like resveratrol may represent a promising supplement to current clinical therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: